IRIS
ROSSI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.865
EU - Europa 2.049
AS - Asia 1.376
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Totale 6.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.848
CN - Cina 1.233
IE - Irlanda 701
UA - Ucraina 325
FI - Finlandia 269
DE - Germania 224
IT - Italia 180
SE - Svezia 114
SG - Singapore 111
GB - Regno Unito 104
BE - Belgio 50
FR - Francia 34
RU - Federazione Russa 28
JP - Giappone 14
CA - Canada 13
IR - Iran 10
NL - Olanda 7
CZ - Repubblica Ceca 6
IN - India 4
MX - Messico 4
AU - Australia 3
EU - Europa 3
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BO - Bolivia 1
BR - Brasile 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
LT - Lituania 1
MU - Mauritius 1
PL - Polonia 1
RS - Serbia 1
TR - Turchia 1
VN - Vietnam 1
Totale 6.300
Salva come PNG Salva come JPEG
Città #
Dublin 700
Chandler 657
Jacksonville 383
Nanjing 322
Ann Arbor 235
Beijing 198
Boardman 177
Ashburn 176
Nanchang 127
Princeton 111
Lawrence 109
Shenyang 103
Wilmington 99
Medford 95
Helsinki 93
Changsha 88
Hebei 81
Shanghai 67
Singapore 66
Jiaxing 62
Woodbridge 62
Tianjin 58
Hangzhou 55
Brussels 50
New York 42
Milan 40
Pavia 38
Los Angeles 27
Verona 27
Munich 25
Houston 20
Washington 20
Dearborn 18
Seattle 17
Auburn Hills 15
Fairfield 14
Norwalk 14
Kunming 12
San Giuliano Milanese 11
Tokyo 10
Jinan 9
Toronto 9
Des Moines 8
Dallas 7
Falkenstein 7
Ningbo 7
Brno 6
Falls Church 6
San Francisco 6
Chicago 5
Piscataway 5
Zhengzhou 5
Atlanta 4
Lanzhou 4
Redwood City 4
San Diego 4
Ardabil 3
Changchun 3
Duncan 3
Guangzhou 3
Ottawa 3
Redmond 3
Rome 3
San Miguel de Allende 3
Andover 2
Berlin 2
Brugherio 2
Cambridge 2
Ergolding 2
Frankfurt am Main 2
Genova 2
London 2
Maranello 2
Melbourne 2
Monmouth Junction 2
Nuremberg 2
Orange 2
Pescara 2
Pune 2
St Petersburg 2
Taizhou 2
Teano 2
Zanjan 2
Amsterdam 1
Augusta 1
Baqiao 1
Belgrade 1
Bhavnagar 1
Bolton 1
Cadelbosco Di Sopra 1
Chongqing 1
Clifton 1
Croom 1
Cupertino 1
Delhi 1
Ercolano 1
Forest City 1
Hefei 1
Horben 1
Jiaozuo 1
Totale 4.699
Salva come PNG Salva come JPEG
Nome #
Kinetic and structural evidences on human prolidase pathological mutants suggest strategies for enzyme functional rescue 106
Improved prolidase activity assay allowed enzyme kinetic characterization and faster prolidase deficiency diagnosis 102
Partial rescue of biochemical parameters after hematopoietic stem cell transplantation in a patient with prolidase deficiency due to two novel PEPD mutations 99
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. 96
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 92
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 92
Cartilage histogenesis in a murine model of chondrodysplasia 91
Stability and networks of hydrogen bonds of the collagen triple helical structure: influence of pH and chaotropic nature of three anions. 90
Matrix disruptions, growth, and degradation of cartilage with impaired sulfation. 90
Adesion proteins in CHO cells. 88
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 86
A novel splicing mutation causes an undescribed type of analbuminemia. 86
Diastrophic Dysplasia Sulfate Transporter (SLC26A2) Is Expressed in the Adrenal Cortex and Regulates Aldosterone Secretion. 84
Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach 82
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 81
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 80
Neutrophil granulocytes uniquely express, among human blood cells, high levels of Methionine-sulfoxide-reductase enzymes. 79
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 79
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 77
Methionine sulfoxide reductase enzymes (Msr): a comparative analysis of the levels of expression in human blood cells 77
Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients. 76
Interaction of decorin with CNBr peptides from collagens I and II. Evidence for multiple binding sites and essential lysyl residues in collagen 75
Altered signaling in the G1 phase deregulates chondrocyte growth in a mouse model with proteoglycan undersulfation. 75
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 75
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 73
Comparative analysis of the expression of methionine sulfoxide reductase enzymes in human blood cells 73
A Mn(II)-Mn(II) center in human prolidase 72
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 72
Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin 71
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 69
Molecular diagnosis of analbuminemia: A novel mutation identified in two amerindian and two Turkish families 68
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. 68
4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion 68
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 67
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 67
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 66
Analbuminemia in a Swiss family is caused by a C --> T transition at nucleotide 4446 of the albumin gene. 66
Lack of prolidase causes a bone phenotype both in human and in mouse 66
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 65
Alteration of proteoglycan sulfation affects bone growth and remodeling. 65
Role of the advanced glycation end products receptor in Crohn’s disease inflammation 65
Stability of type I collagen peptide trimers. 64
Novel nonsense mutation causes analbuminemia in a Moroccan family. 64
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 64
Effect of the triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in human skin fibroblast cultures. 64
N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia 63
Self-aggregation of fibrillar collagens I and II involves lysine side chains. 63
The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta 61
Altered cytoskeletal organization characterized lethal but not surviving Brtl+/- mice: insight on phenotypic variability in osteogenesis imperfecta 61
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification 61
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 60
A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans. 60
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 60
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. 59
Mucosal expression of the receptor for the advanced glycation end products (RAGE) in patients with inflammatory bowel disease (IBD) 59
Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica 59
A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations 58
A novel mutation in the sulphate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia. 58
Type I collagen CNBr peptides: species and behavior in solution 56
Early Fracture Healing is Delayed in the Col1a2 +/G610C Osteogenesis Imperfecta Murine Model 56
Ultrastructural aspects of cartilage histogenesis in a model of chondrodysplasia 56
Achondrogenesis type 1B is caused by mutations in the diastrophic dysplasia sulfate transporter gene 55
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 54
Polyethylene Glycol-Poly-Lactide-co-Glycolide Block Copolymer-Based Nanoparticles as a Potential Tool for Off-Label Use of N-Acetylcysteine in the Treatment of Diastrophic Dysplasia 54
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 54
The receptor for the advanced glycation end products is overexpressed in the intestinal mucosa of patients with crohn’s disease 53
Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. 52
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 52
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis. 52
EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and collagen expression in the exostoses. 52
Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype 52
Diastrophic dysplasia sulfate transporter (DTDST) gene is not involved in pseudodiastrophic dysplasia 51
New dysplasia or achondrogenesis type 1 B? The importance of histology and molecular biology in delineating skeletal dysplasias. 51
Fast screening of glycosaminoglycan disaccharides by fluorophore-assisted carbohydrate electrophoresis (FACE): applications to biologic samples and pharmaceutical formulations 51
Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for a Leu483Pro substitution in the diastrophic dysplasia sulfate transporter 50
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 50
Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate 50
Genetic variants of human serum albumin in Italy: point mutants and a carboxyl-terminal variant. 48
A nucleotide insertion and frameshift cause albumin Kenitra, an extended and O-glycosylated mutant of human serum albumin with two additional disulfide bridges. 48
Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia. 47
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 46
Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta. 46
Physiological Performance of a Detergent Decellularized Heart Valve Implanted for 15 Months in Vietnamese Pigs: Surgical Procedure, Follow-up, and Explant Inspection. 45
Bone and connective tissue disorders caused by defects in glycosaminoglycan biosynthesis: a panoramic view 45
Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production 44
Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes and diagnostic relevance. 43
Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: congenital dislocations and vertebral changes as principal diagnostic features 43
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 41
Chondroitin Sulfate N-acetylgalactosaminyltransferase-1 (CSGalNAcT-1) Deficiency Results in a Mild Skeletal Dysplasia and Joint Laxity 40
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias 40
Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2 40
Infantile systemic hyalinosis in siblings: clinical report, biochemical and ultrastructural findings, and review of the literature. 38
Analysis of proteoglycan synthesis and secretion in cell culture systems 38
The Lysosomal Protein Arylsulfatase B Is a Key Enzyme Involved in Skeletal Turnover 37
Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes 37
Genetic variants of human serum albumin: molecular defects and biological stability. 36
Chondrodysplasia and abnormal joint development associated with mutations in IMPAD1, encoding the Golgi-resident nucleotide phosphatase, gPAPP 36
Skeletal Dysplasias Caused by Sulfation Defects 36
FACE analysis as a fast and reliable methodology to monitor the sulfation and total amount of chondroitin sulfate in biological samples of clinical importance. 35
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 34
Totale 6.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020493 0 0 0 0 7 69 11 91 9 155 134 17
2020/2021672 78 69 39 68 7 75 13 102 29 91 82 19
2021/2022528 12 10 14 13 13 9 13 40 21 18 87 278
2022/20231.871 180 175 15 151 194 165 6 88 804 20 46 27
2023/2024664 90 141 25 48 63 155 15 40 9 24 28 26
2024/2025328 54 133 61 61 19 0 0 0 0 0 0 0
Totale 6.491